Contrary to the hypothesis that those upregulated candidate genes might be a survival benefit for ovarian cancer, high IGFBP4 and TGFBI gene expressions were associated with decreased OS rather than prolonged survival (Figure 3). Here, IGFBP4 is linked to ovarian carcinoma.